Tenapanor's sustained response in patients with constipation predominant irritable bowel syndrome: Post-hoc analysis from a 12-week, double-blind, placebo-controlled, randomized phase 2B trial

Category Primary study
ConferenceAmerican Journal of Gastroenterology
Year 2015
This article has no abstract
Epistemonikos ID: 04c012f764feb043c3ad05169e4b3b87df34ed40
First added on: Apr 30, 2026